BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8301135)

  • 1. Characteristics of a novel low affinity complement C3dg-binding protein of human platelets.
    Chen H; Marjan J; Cox AD; Devine DV
    J Immunol; 1994 Feb; 152(3):1332-8. PubMed ID: 8301135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular distribution of complement receptor type 4 (CR4): expression on human platelets.
    Vik DP; Fearon DT
    J Immunol; 1987 Jan; 138(1):254-8. PubMed ID: 2946777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
    Vik DP; Fearon DT
    J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2.
    Diefenbach RJ; Isenman DE
    J Immunol; 1995 Mar; 154(5):2303-20. PubMed ID: 7868901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes.
    Gerardy-Schahn R; Ambrosius D; Saunders D; Casaretto M; Mittler C; Karwarth G; Görgen S; Bitter-Suermann D
    Eur J Immunol; 1989 Jun; 19(6):1095-102. PubMed ID: 2666143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of a specific C3a receptor on guinea pig platelets.
    Fukuoka Y; Hugli TE
    J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a C3b/iC3 binding protein of rabbit platelets and leukocytes. A CR1-like candidate for the immune adherence receptor.
    Manthei U; Nickells MW; Barnes SH; Ballard LL; Cui WY; Atkinson JP
    J Immunol; 1988 Feb; 140(4):1228-35. PubMed ID: 2963863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet C1q receptor interactions with collagen- and C1q-coated surfaces.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1990 Nov; 145(9):2984-8. PubMed ID: 2212670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel 33-kDa C1q-binding site on human blood platelets.
    Peerschke EI; Reid KB; Ghebrehiwet B
    J Immunol; 1994 Jun; 152(12):5896-901. PubMed ID: 8207215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human blood platelets possess specific binding sites for C1q.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1987 Mar; 138(5):1537-41. PubMed ID: 3492557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin.
    Scandura JM; Ahmad SS; Walsh PN
    Biochemistry; 1996 Jul; 35(27):8890-902. PubMed ID: 8688425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement (C3b) interaction with the human granulocyte receptor: correlation of binding of fluid-phase radiolabeled ligand with histaminase release.
    Melamed J; Arnaout MA; Colten HR
    J Immunol; 1982 May; 128(5):2313-8. PubMed ID: 6801135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21).
    Prodinger WM; Schwendinger MG; Schoch J; Köchle M; Larcher C; Dierich MP
    J Immunol; 1998 Nov; 161(9):4604-10. PubMed ID: 9794388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and partial characterization of human platelet C1q binding sites.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1988 Nov; 141(10):3505-11. PubMed ID: 3183380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
    Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
    Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on fibronectin and its domains. I. Novel recombinant cell-binding domain of fibronectin--a modulator of human platelet functions.
    Vogel T; Werber MM; Guy R; Levanon A; Nimrod A; Legrand C; Gorecki M; Eldor A; Panet A
    Arch Biochem Biophys; 1993 Jan; 300(1):501-9. PubMed ID: 8424687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactions of immunoglobulin G-binding ligands with platelets and platelet-associated immunoglobulin G.
    Rosse WF; Devine DV; Ware R
    J Clin Invest; 1984 Feb; 73(2):489-96. PubMed ID: 6699173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation.
    Rouhiainen A; Imai S; Rauvala H; Parkkinen J
    Thromb Haemost; 2000 Dec; 84(6):1087-94. PubMed ID: 11154118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human platelets possess receptors for a lymphokine: demonstration of high specific receptors for HuIFN-gamma.
    Molinas FC; Wietzerbin J; Falcoff E
    J Immunol; 1987 Feb; 138(3):802-6. PubMed ID: 2949008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.